Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate The Efficacy of Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control For Treatment Of Insomnia.

NCT04452981 is registered in ClinicalTrials.gov with Neurovalens Ltd. as lead sponsor.

NCT NCT04452981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate The Efficacy of Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control For Treatment Of Insomnia.
Lead sponsor
Neurovalens Ltd.
Phase
Not applicable
Overall status
Completed
Start date
June 15, 2022
Completion date
January 3, 2023
Enrollment
153 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, sleep disturbance